Pharmaceutical market access is not easy. It can seem fickle, lengthy and very complicated. Ensuring that your medicines get to the patients that need them involves dealing with clinicians, payers, HTA bodies and internal and external stakeholders. Just as you think you understand the rules of the game, they change. Value based pricing anyone?
It is perhaps no surprise that the service community is rising to the challenge and offering a range of solutions to help organisations get their treatments to patients. They can assist in value demonstration, interpretation of policy developments and health outcomes generation. They can help you develop the right pricing model and assist in the launch sequence planning. They can also provide you with strategic consulting services or find you the people with the skills set that you need.
In this ebook, we take a look at the top market access services required by pharma together with some companies that work in this area. I hope you find it useful
February 2014 will see London play host to Pharma Pricing & Market Access Outlook Europe. The 8th Annual event is the worlds largest market access meeting and has high level representation from pharma and government payers across the world. We'd love for you to join.
Click here for more information.